선호 종목, 경제 이벤트, 팔로우하는 저자들의 글 업데이트를 받으시려면 회원가입을 해주세요.
무료 회원가입 이미 계정이 있으세요? 로그인
바이오테크놀로지 부문 회사들의 글로벌 주식에 대한 시장 성과로부터 이익을 얻고, 벤치마크를 초과하는 성과를 내기 위하여 일임 운용을 활용하는 것입니다
종목명 | 헤드라인 | 재직 시작연도 | 기간 |
---|---|---|---|
Servaas Michielssens | - | 2024 | now |
전기 | Servaas Michielssens has been a Senior Analyst at Candriam since 2016, and became co-manager of the Biotechnology and Oncology strategy since November 2018. He began his career as a PhD student at the University of Leuven Belgium in 2007, where he obtained his PhD in science in 2011. In 2012 he became a postdoctoral scholar at the Max Planck Institute for Biophysical Chemistry in Germany. Servaas holds a master degree in chemistry from the University of Leuven, Belgium and a PhD in science from the same university. Servaas is also a CFA charterholder. | ||
Linden Thomson | - | 2024 | now |
Rudi Van den Eynde | Senior Portfolio Manager, Equities | 2000 | now |
전기 | Due to European regulatory GDPR guidelines, Candriam cannot provide personal details as education or professional background to databases outside Europe. Information available on request only. | ||
Servaas Michielssens | - | 2019 | 2022 |
전기 | Servaas Michielssens has been a Senior Analyst at Candriam since 2016, and became co-manager of the Biotechnology and Oncology strategy since November 2018. He began his career as a PhD student at the University of Leuven Belgium in 2007, where he obtained his PhD in science in 2011. In 2012 he became a postdoctoral scholar at the Max Planck Institute for Biophysical Chemistry in Germany. Servaas holds a master degree in chemistry from the University of Leuven, Belgium and a PhD in science from the same university. Servaas is also a CFA charterholder. | ||
Ward Capoen | - | 2015 | 2016 |
%USER_NAME%(을)를 정말로 차단하시겠습니까?
그렇게 하면, 귀하와 %USER_NAME%(은)는 서로의 Investing.com 게시물을 볼 수 없습니다.
%USER_NAME%(은)는 차단 명단에 추가되었습니다.
방금 이 사람을 차단해제하였으므로 48시간 이후에 차단을 재개할 수 있습니다.
나는 이 의견이 다음과 같다고 생각합니다:
감사합니다!
귀하의 보고는 검토를 위해 조정자에게 보내졌습니다.